The health system’s operating margin for 2023 was 1.4%, compared to -1.5% the previous year.
Revenue increased 14.3% year over year to $7.3 billion while expenses grew by 11% to $7.2 billion, according to financial documents published April 29. Salaries and wages increased 5.3% year over year to $3.2 billion while supply costs grew by 18.3% to $1.7 billion.
After accounting for nonoperating items, such as investment returns, Ochner ended 2023 with a net income of $196.8 million, compared to a net loss of $185 million in 2022.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
